Phio Pharmaceuticals Announces Positive Pathology Results in Third Cohort in INTASYL PH-762 Skin Cancer Clinical Trial
Complete Pathologic Response reported in 2 patients in the Third Cohort with cutaneous squamous cell carcinoma, complementing results in prior cohort Phio to present trial results to date at a podium presentation at Society for Investigative Dermatology (SID) Annual Meeting on May 10thMarlborough, Massachusetts--(Newsfile Corp. - May 7, 2025) -...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-07 7:45 AM EDT | Phio Pharmaceuticals Corp.
NervGen Pharma Announces Results of Annual General Meeting of Shareholders
All resolutions submitted for approval were passed by shareholdersVancouver, British Columbia--(Newsfile Corp. - May 7, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, announces the results of its Annual General Meeting of Shareholders ("AGM") held on May 6, 2025.The company...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-07 7:30 AM EDT | NervGen Pharma Corp.
CareRx Reports Results for the First Quarter of 2025
Toronto, Ontario--(Newsfile Corp. - May 7, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or the "Company"), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today reported its financial results for the first quarter ended March 31, 2025."Over the past several quarters, we have made...
2025-05-07 7:00 AM EDT | CareRx Corporation
HEALWELL AI to Announce Fiscal First Quarter 2025 Financial Results on May 13, 2025
HEALWELL AI to hold a conference call and simultaneous webcast on Tuesday, May 13, 2025, at 1:00 pm ET (10:00 am PT). Toronto, Ontario--(Newsfile Corp. - May 6, 2025) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care,...
Technology, Healthcare and Hospitals
2025-05-06 3:15 AM EDT | HEALWELL AI
FendX Announces Share Issuance Pursuant to IP License Agreement
Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, announces it has completed the issuance of common shares as consideration under the exclusive intellectual property...
Technology, Healthcare and Hospitals, Health
2025-05-05 8:00 PM EDT | FendX Technologies Inc.
Adia Nutrition Announces Major Share Structure Overhaul with Retirement of Approximately 15 Million Shares and Cancellation of 10 Million Share Commitment
Winter Park, Florida--(Newsfile Corp. - May 5, 2025) - Adia Nutrition, Inc. (OTC Pink: ADIA), a Winter Park, Florida-based innovator in health and wellness, is excited to announce a transformative overhaul of its share structure, including the retirement of approximately 15 million shares, reducing the outstanding common stock from 95,899,861...
Healthcare and Hospitals, Health
2025-05-05 11:02 AM EDT | Adia Nutrition Inc.
IR-MED Awarded $500,000 Grant from the Israel Innovation Authority to Advance AI-Powered DiaSafe(TM) Device for Diabetic Foot Ulcer Assessment
DiaSafe™, IR-MED's second product, is being developed to provide safe, real-time optical readings of biomarkers for assessment of diabetic foot ulcers The most common cause of amputation, diabetic foot ulcers can be prevented with early assessment, improving patient care and healthcare economics in a
Technology, Biotechnology, Healthcare and Hospitals, Health
2025-05-05 8:30 AM EDT | IR-MED, Inc.
Theralase Clinical Data Presented at Canadian Bladder Cancer Forum and American Urological Association
Toronto, Ontario--(Newsfile Corp. - May 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of small molecules and their formulations, able to be activated by light, radiation, sound and/or other drugs, intended for the...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-05-05 7:00 AM EDT | Theralase Technologies Inc.
Cosmo Highlights Strategic AI and GI Innovation Agenda at Digestive Disease Week(R) 2025
Dublin, Ireland--(Newsfile Corp. - May 5, 2025) - Cosmo is attending this year’s Digestive Disease Week® (DDW), held in San Diego, California from May 3-6, where its leadership team is advancing a focused agenda of strategic meetings with key...
Healthcare and Hospitals, Health
2025-05-05 12:59 AM EDT | Cosmo Pharmaceuticals N.V.
Cosmo Announces EU MDR Certification for Endovision's Cerebro, expanding its real-time AI ecosystem
Dublin, Ireland--(Newsfile Corp. - May 2, 2025) - Cosmo is excited to announce that Endovision Limited, a leading innovator in endoscopic imaging solutions, has received EU MDR certification[1] for Cerebro, a Real-Time AI-powered guide for complete Esophagogastroduodenoscopy (EGD) procedures....
Healthcare and Hospitals, Health
2025-05-02 1:08 AM EDT | Cosmo Pharmaceuticals N.V.
Envoy Medical Reports on First Quarter 2025 Results
White Bear Lake, Minnesota--(Newsfile Corp. - May 1, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the first quarter ended March 31, 2025, as well as other subsequent events.Financial and...
Biotechnology, Healthcare and Hospitals
2025-05-01 4:30 PM EDT | Envoy Medical, Inc.
CIA Legacy Awards Recognize Leaders in Canadian Actuarial Profession
Ottawa, Ontario--(Newsfile Corp. - May 1, 2025) - The Canadian Institute of Actuaries (CIA) is proud to recognize the extraordinary contributions of our volunteers, whose commitment helps drive the development and success of the actuarial profession in Canada. Each year, the CIA recognizes volunteers who have reached milestones through the...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 1:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Les Prix du patrimoine de l'ICA récompensent les chefs de file de la profession actuarielle au Canada
Ottawa, Ontario--(Newsfile Corp. - 1 mai 2025) - L'Institut canadien des actuaires (ICA) est fier de souligner les contributions exceptionnelles de nos bénévoles, dont l'engagement contribue au développement et au succès de la profession actuarielle au Canada. Chaque année, l'ICA reconnaît les étapes importantes qu'ils et elles ont franchies lors...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 1:00 PM EDT | Canadian Institute of Actuaries / FR: Institut canadien des actuaires
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Marlborough, Massachusetts--(Newsfile Corp. - May 1, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Mr. Robert Bitterman, CEO and Chairman of the Board, Phio Pharmaceuticals will present an update...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-05-01 7:45 AM EDT | Phio Pharmaceuticals Corp.
Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today announced that the company has launched Elite's generic version of Percocet® (oxycodone hydrochloride and acetaminophen tablets, USP CII) 5mg/325mg, 7.5mg/325mg and 10mg/325mg tablets. Oxycodone...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-30 4:30 PM EDT | Elite Pharmaceuticals, Inc.
NuGen Announces Release of 2024 Annual Financial Results
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of 2024 Annual Financial Results. Annual Financial Statements Reflect Commercial Ramp UpThe orders announced previously in 2024...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-30 4:30 PM EDT | NuGen Medical Devices Inc.
Bachem Annual General Meeting 2025
All proposals of the Board of Directors approved. Dividend of CHF 0.85 per share. ...
Biotechnology, Chemical, Healthcare and Hospitals, Pharmaceuticals
2025-04-30 11:55 AM EDT | Bachem Holding AG
CareRx Corporation to Host First Quarter 2025 Financial Results Conference Call on Wednesday, May 7, 2025 at 10:30 a.m. ET
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - CareRx Corporation (TSX: CRRX) ("CareRx" or "the Company") today announced it will host a conference call, including a slide presentation, to discuss its first quarter 2025 financial results on Wednesday, May 7, 2025, at 10:30 a.m. Eastern Time (ET). The Company expects...
2025-04-30 7:00 AM EDT | CareRx Corporation
LevelJump Announces Anticipated Delay in Filing Year-End Reporting Documents
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") wishes to advise shareholders that its annual audited financial statements for the fiscal year ending December 31, 2024, will not be completed by the filing deadline of April 30, 2025 (the "Filing Deadline")....
Healthcare and Hospitals, Health
2025-04-30 6:00 AM EDT | LevelJump Healthcare Corp.